Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

Autor: Powles, Thomas, Assaf, Zoe June, Degaonkar, Viraj, Grivas, Petros, Hussain, Maha, Oudard, Stephane, Gschwend, Jürgen E., Albers, Peter, Castellano, Daniel, Nishiyama, Hiroyuki, Daneshmand, Siamak, Sharma, Shruti, Sethi, Himanshu, Aleshin, Alexey, Shi, Yi, Davarpanah, Nicole, Carter, Corey, Bellmunt, Joaquim, Mariathasan, Sanjeev
Zdroj: In European Urology February 2024 85(2):114-122
Databáze: ScienceDirect
Externí odkaz: